A carregar...

Safety of adjuvant endocrine therapies in hormone receptor–positive early breast cancer

Postmenopausal patients with hormone-sensitive early breast cancer are typically treated with adjuvant endocrine therapy, which significantly reduces the risk of recurrence. Because treatment is of a long duration, side effects from adjuvant therapy can be problematic. The aromatase inhibitors (AIS)...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Sehdev, S., Martin, G., Sideris, L., Lam, W., Brisson, S.
Formato: Artigo
Idioma:Inglês
Publicado em: Multimed Inc. 2009
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2722047/
https://ncbi.nlm.nih.gov/pubmed/19672417
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!